Cjc1295

CJC-1295 is a synthetic peptide analog of growth hormone-releasing hormone (GHRH) that has been studied for its potential role in stimulating the release of growth hormone (GH) and insulin-like growth factor 1 (IGF-1). It is designed to enhance the half-life of endogenous GHRH through its ability to bind to albumin, prolonging its activity in the body.

Preclinical research on CJC-1295 has explored its effects on muscle growth, fat metabolism, recovery, and cellular regeneration. Studies suggest that by increasing GH secretion, it may influence anabolic processes, support tissue repair, and modulate metabolic function.

This compound is intended strictly for research purposes only and is not approved for human consumption. It is not for medical, dietary, or therapeutic use. Researchers continue to investigate its potential applications in endocrinology and metabolic studies.